Tacrolimus is a calcineurin inhibitor (CNI). It inhibits T-cell proliferation by binding to FK506 binding protein (FKBP).

The following are pharmacologic parameters of tacrolimus

- **Metabolism:**CYP3A4, CYP3A5, P-glycoprotein (PGP)/ABCB1

- **Metabolites:**Fifteen possible; chief breakdown metabolite: 13-O-dimethyl-tacrolimus

- **Enzymes Inhibited**: CYP3A4

- **Half-Life:**4 to 41 h (about 12 h on average)****

- **The volume of Distribution (using plasma separated at 37 degrees C):**approximately 30 L/kg****

- **Clearance (using plasma separated at 37 degrees C):**1.69 +/- 0.57 L/h/kg

- **Excretion:**Biliary route (approximately 95%), urinary excretion (approximately 2.4% as unchanged drug)